Skip to content

Annexon ANNX Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.22M-35.9%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$609K-64.2%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$493K
Janux Therapeutics logo
Janux TherapeuticsJANX
$2.62M-37.8%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$849K-35.4%

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
Operating cash flow-$46.8M+6.5%
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$868.37M+233%
Enterprise value$718.59M+274%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: Annexon’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Annexon's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Annexon's accretion (amortization) of discounts and premiums, investments?
Annexon (ANNX) reported accretion (amortization) of discounts and premiums, investments of $632K in Q1 2026.
How has Annexon's accretion (amortization) of discounts and premiums, investments changed year-over-year?
Annexon's accretion (amortization) of discounts and premiums, investments decreased by 65.8% year-over-year, from $1.85M to $632K.
What is the long-term trend for Annexon's accretion (amortization) of discounts and premiums, investments?
Over 3 years (2021 to 2025), Annexon's accretion (amortization) of discounts and premiums, investments has grown at a 47.3% compound annual growth rate (CAGR), from -$1.25M to $4.01M.
What does accretion (amortization) of discounts and premiums, investments mean?
This represents the non-cash adjustment to net income resulting from the amortization of premiums or the accretion of discounts on debt securities held as investments. It reflects the gradual adjustment of the carrying value of investment assets toward their par value over time. This adjustment is necessary to reconcile net income with actual cash flows from operating activities.